FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,508,000 | -68.7% | 67,300 | -65.4% | 0.20% | -72.7% |
| Q2 2022 | $4,817,000 | -39.7% | 194,400 | -5.6% | 0.75% | -27.1% |
| Q1 2022 | $7,983,000 | +1650.7% | 205,900 | +2539.7% | 1.03% | +2139.1% |
| Q4 2021 | $456,000 | -26.6% | 7,800 | +14.2% | 0.05% | -43.9% |
| Q4 2020 | $621,000 | +60.1% | 6,830 | -29.7% | 0.08% | -60.2% |
| Q3 2020 | $388,000 | -65.7% | 9,712 | -70.6% | 0.21% | -68.1% |
| Q2 2020 | $1,132,000 | +407.6% | 33,000 | +189.5% | 0.64% | +200.0% |
| Q4 2019 | $223,000 | – | 11,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |